Press Release
Category Added in a WPeMatico Campaign
-
Cision PR Newswire9 April 2026
Boost Run and Willow Lane Announce Effectiveness of Registration Statement in Connection with Proposed Business Combination
Extraordinary General Meeting of Willow Lane Shareholders to Approve Business Combination Scheduled for April 30, 2026 Upon Closing, Combined Company…
Read More » -
Cision PR Newswire9 April 2026
Boost Run and Willow Lane Announce Effectiveness of Registration Statement in Connection with Proposed Business Combination
Extraordinary General Meeting of Willow Lane Shareholders to Approve Business Combination Scheduled for April 30, 2026 Upon Closing, Combined Company…
Read More » -
Cision PR Newswire9 April 2026
Boost Run and Willow Lane Announce Effectiveness of Registration Statement in Connection with Proposed Business Combination
Extraordinary General Meeting of Willow Lane Shareholders to Approve Business Combination Scheduled for April 30, 2026 Upon Closing, Combined Company…
Read More » -
Cision PR Newswire9 April 2026
QuickLogic Will Demonstrate Its RadPro™ FPGA Dev Kit at HEART Conference
The RadPro Dev Kit enables Defense Industrial Base (DIB) evaluation of QuickLogic’s U.S. fabricated Radiation Hardened RadPro FPGA Demonstration will…
Read More » -
Cision PR Newswire9 April 2026
QuickLogic Will Demonstrate Its RadPro™ FPGA Dev Kit at HEART Conference
The RadPro Dev Kit enables Defense Industrial Base (DIB) evaluation of QuickLogic’s U.S. fabricated Radiation Hardened RadPro FPGA Demonstration will…
Read More » -
Cision PR Newswire9 April 2026
QuickLogic Will Demonstrate Its RadPro™ FPGA Dev Kit at HEART Conference
The RadPro Dev Kit enables Defense Industrial Base (DIB) evaluation of QuickLogic’s U.S. fabricated Radiation Hardened RadPro FPGA Demonstration will…
Read More » -
Cision PR Newswire9 April 2026
OncoC4 announces first participant’s dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer’s disease
ROCKVILLE, Md., April 9, 2026 /PRNewswire/ — OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant’s dosing following…
Read More » -
Cision PR Newswire9 April 2026
OncoC4 announces first participant’s dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer’s disease
ROCKVILLE, Md., April 9, 2026 /PRNewswire/ — OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant’s dosing following…
Read More » -
Cision PR Newswire9 April 2026
OncoC4 announces first participant’s dosing in Phase 1/2 clinical trial of ONC-841 for the treatment of Alzheimer’s disease
ROCKVILLE, Md., April 9, 2026 /PRNewswire/ — OncoC4 Inc., a late clinical stage biopharmaceutical company, today announced first participant’s dosing following…
Read More » -
Cision PR Newswire9 April 2026
In Northern California, Ava Community Energy Debuts SmartHome Battery, a Residential Solar + Storage Program for Community-Powered Energy
The $11+ million program offers residents two incentives to install a home battery that will connect with Ava’s VPP as…
Read More »






